HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John P Quinn Selected Research

RE1-silencing transcription factor

1/2016NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy.
5/2015Characterization of a REST-Regulated Internal Promoter in the Schizophrenia Genome-Wide Associated Gene MIR137.
6/2011Distinct gene expression profiles directed by the isoforms of the transcription factor neuron-restrictive silencer factor in human SK-N-AS neuroblastoma cells.
1/2003Detection of small cell lung cancer by RT-PCR for neuropeptides, neuropeptide receptors, or a splice variant of the neuron restrictive silencer factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John P Quinn Research Topics

Disease

16Infections
08/2013 - 01/2002
6Schizophrenia (Dementia Praecox)
01/2019 - 05/2015
6Mental Disorders (Mental Disorder)
01/2018 - 03/2007
5Polyps
11/2019 - 09/2002
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 11/2020
4Inflammation (Inflammations)
09/2016 - 03/2008
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022 - 01/2019
3Disease Progression
01/2022 - 09/2020
3Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2019
3Migraine Disorders (Migraine)
12/2021 - 10/2018
3Neuroblastoma
01/2017 - 06/2011
3Neurogenic Inflammation
09/2016 - 03/2008
3Seizures (Absence Seizure)
01/2016 - 06/2008
3Pneumonia (Pneumonitis)
10/2010 - 06/2002
2Neuroinflammatory Diseases
12/2021 - 11/2021
2Sarcoma (Soft Tissue Sarcoma)
02/2020 - 10/2018
2Epilepsy (Aura)
10/2018 - 01/2016
2Hyperalgesia
09/2016 - 05/2013
2Pain (Aches)
09/2016 - 10/2004
2Virus Diseases (Viral Diseases)
02/2011 - 03/2008
2Sepsis (Septicemia)
10/2010 - 01/2002
2Intraabdominal Infections
06/2009 - 08/2007
2Mood Disorders (Mood Disorder)
03/2007 - 06/2004
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2003 - 01/2003
1Tauopathies
01/2022
1Juvenile Amyotrophic Lateral Sclerosis 2
01/2022
1Frontotemporal Dementia (Semantic Dementia)
01/2022
1Tobacco Use Disorder (Nicotine Dependence)
01/2020
1Dehydration (Water Stress)
01/2020
1Starvation
11/2019
1Wounds and Injuries (Trauma)
01/2019
1Psychotic Disorders (Schizoaffective Disorder)
01/2019
1Neoplasms (Cancer)
10/2018
1Ischemia
10/2018
1Noncommunicable Diseases
01/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1Cognitive Dysfunction
01/2016
1Autistic Disorder (Autism)
09/2015
1Colitis
05/2014

Drug/Important Bio-Agent (IBA)

7NeuropeptidesIBA
08/2017 - 01/2003
6Retroelements (Retrotransposon)IBA
01/2022 - 01/2014
6TachykininsIBA
01/2017 - 03/2008
5PolyphosphatesIBA
11/2019 - 09/2002
4EnzymesIBA
01/2020 - 09/2002
4Proteins (Proteins, Gene)FDA Link
11/2019 - 01/2010
4Substance PIBA
09/2016 - 03/2008
4RE1-silencing transcription factorIBA
01/2016 - 01/2003
4VancomycinFDA LinkGeneric
09/2011 - 11/2002
3RNA (Ribonucleic Acid)IBA
01/2022 - 01/2017
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
02/2020 - 05/2016
3Phosphotransferases (Kinase)IBA
02/2020 - 10/2013
3Anti-Bacterial Agents (Antibiotics)IBA
08/2013 - 01/2004
2src-Family KinasesIBA
12/2021 - 11/2021
2Biological ProductsIBA
10/2020 - 01/2018
2ElementsIBA
09/2020 - 01/2019
2Phosphorus (Red Phosphorus)IBA
11/2019 - 09/2011
2Transcription Factors (Transcription Factor)IBA
01/2018 - 06/2011
2MicroRNAs (MicroRNA)IBA
01/2017 - 10/2016
2CytokinesIBA
09/2016 - 10/2010
2Tachykinin Receptors (Tachykinin Receptor)IBA
09/2016 - 05/2013
2Capsaicin (Zostrix)FDA Link
09/2016 - 05/2013
2Neurokinin AIBA
09/2016 - 05/2013
2Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
05/2014 - 10/2010
2SolutionsIBA
05/2014 - 09/2002
2DaptomycinFDA Link
09/2011 - 08/2005
2Peptides (Polypeptides)IBA
10/2010 - 03/2008
2Kainic Acid (Kainate)IBA
01/2010 - 06/2008
2beta-LactamsIBA
06/2009 - 12/2005
2Ceftriaxone (Ceftriaxon)FDA LinkGeneric
10/2007 - 08/2007
2ImipenemFDA Link
10/2007 - 09/2006
2Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
10/2007 - 08/2007
2Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
03/2007 - 06/2004
2Linezolid (Zyvox)FDA Link
11/2003 - 11/2002
1Galectin 3 (LGALS3)IBA
01/2022
1DNA Transposable Elements (Element, IS)IBA
01/2022
1Purinergic P2X7 ReceptorsIBA
12/2021
1Calcitonin Gene-Related PeptideIBA
11/2021
1AnkyrinsIBA
11/2021
1Apolipoproteins E (ApoE)IBA
01/2021
1Phosphates (Orthophosphate)IBA
11/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
15- (alpha- methyl- 4- bromobenzylamino)phosphonomethyl- 1,4- dihydroquinoxaline- 2,3- dioneIBA
10/2018
1AminesIBA
10/2018
1FlavonoidsIBA
01/2018
1ResveratrolIBA
01/2018
1Psychotropic Drugs (Psychoactive Drugs)IBA
01/2017
1Antidepressive Agents (Antidepressants)IBA
01/2017
1Tryptases (Tryptase)IBA
09/2016
1N-Methylaspartate (NMDA)IBA
05/2016
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2016
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1trimethyl-lysine hydroxylaseIBA
09/2015
1Dextran SulfateIBA
05/2014
1netupitantIBA
05/2014
1NAD kinaseIBA
10/2013
1exopolyphosphataseIBA
10/2013

Therapy/Procedure

8Therapeutics
11/2021 - 06/2002
1Fluid Therapy (Oral Rehydration Therapy)
01/2020
1Oral Administration
05/2014